Development and external validation of a prognostic nomogram for event-free survival in resectable non-small cell lung cancer after neoadjuvant chemoimmunotherapy
BackgroundCombining multiple prognostic factors can enhance risk assessment for resected non-small cell lung cancer (NSCLC). Our aim was to evaluate the prognostic significance of ypT staging, ypN staging, major pathologic response (MPR) and pathology response in lymph node, and to develop a combine...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2025-12-01
|
| סדרה: | Frontiers in Oncology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1682497/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
